Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease (NCT04123314)
Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease
🩺 Plain-English Summary (8th-Grade Level)
This open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocybin may improve quality of life in those individuals.
Who can join: Review the eligibility criteria below.
Location: Johns Hopkins Center for Psychedelic and Consciousness Research — Baltimore, Maryland
Age range: 18 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Johns Hopkins Center for Psychedelic and Consciousness Research — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: (410) 550-5466
Email: igeithn1@jhmi.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Depressive Symptoms
- Evaluating a Virtual Mentoring Program Plus Mental Health Videos for Teens — Oakland, California
- JAK Signaling in Depression and Cognition in Male Football Players — Atlanta, Georgia
- Family Spirit Strengths — Chinle, Arizona
- Our Voices Matter: Intervention for Depression in Youth — Chicago, Illinois
- rTMS for Military TBI-related Depression — Palo Alto, California
- BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women — Winter Garden, Florida
Explore by condition: All Depressive Symptoms clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.